A61P 35 - Antineoplastic agents

Patents for A61P 35 - Antineoplastic agents (221,099)
11/1997
11/19/1997	EP0806956A1 Use of 5'substituted nucleosides to provide resistance in cytostatic treatment and medicaments containing said nucleosides
11/19/1997	EP0806954A1 Inhibition of the degradation of connective tissue matrix protein components in mammals
11/19/1997	EP0806946A2 Use of carotinoids for preparing medicaments for treating dermatoses
11/19/1997	EP0557300B1 Bispecific antibodies, method of production, and uses thereof
11/19/1997	EP0341252B1 Human polymorphic epithelial mucin polypeptides for use in therapy and diagnosis
11/19/1997	CN1165483A Compositions of ciplatin in comination with 2,2'-dithio-bis (ethanesulfonate) (dinesna)
11/19/1997	CN1165481A Method and compositions for inhibiting protein kinases
11/18/1997	US5688992 Compounds for treatment of signaling pathways in immune disfunction, cancer and diabetes
11/18/1997	US5688957 (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!aryl and (3"-thioxacyclohex-1"-enyl)!-but-3'-ene-1'-ynyl!heteroaryl carboxylic acids and esters having retinoid-like biological activity
11/18/1997	US5688926 Process of preparing etoposide phosphate and etoposide
11/18/1997	US5688925 Glycosylation or etherification as antitumor agents
11/18/1997	US5688922 Chemical intermediates for glycyrrhetinic acid derivatives, selectin ligands, inhibitors of leukotriene biosynthesis
11/18/1997	US5688918 Antitumor
11/18/1997	US5688796 Heterocyclic substituted benzothiophenes, compositions, and methods
11/18/1997	US5688773 Method of selectively destroying neoplastic cells
11/18/1997	US5688665 Binding to cyclin dependent kinases; controlling cell reproduction
11/18/1997	US5688529 Immunosuppresants, antiinflammatory, antitumor, antiproliferative, antiviral, antipsoriatic agents
11/18/1997	US5688506 Immunogens against gonadotropin releasing hormone
11/18/1997	US5688505 Method for treating cancer with monoclonal antibodies to oncofetal protein
11/18/1997	US5688504 Antagonists
11/18/1997	CA2049160C Water soluble derivatives of taxol
11/13/1997	WO1997042337A1 Gene expression in monocytes and macrophages
11/13/1997	WO1997042329A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
11/13/1997	WO1997042224A1 Neurotactin and uses therefor
11/13/1997	WO1997042223A1 hGH-RH(1-29)NH2 ANALOGUES HAVING ANTAGONISTIC ACTIVITY
11/13/1997	WO1997042222A1 Methods and means for inhibition of cdk4 activity
11/13/1997	WO1997042219A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR
11/13/1997	WO1997042218A1 MAMMALIAN SEX COMB ON MIDLEG (MAMMALIAN Scm) ACTS AS AN ONCOGENE
11/13/1997	WO1997042213A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS AN ONCOGENE
11/13/1997	WO1997042211A1 Mammalian sex comb on midleg (mammalian scm) acts as a tumor suppressor
11/13/1997	WO1997042187A1 Oxindole derivatives
11/13/1997	WO1997042174A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
11/13/1997	WO1997041898A1 Targeted combination immunotherapy of cancer
11/13/1997	WO1997041886A1 Stimulation of host defence mechanisms against tumors
11/13/1997	WO1997041884A1 Method of treatment
11/13/1997	WO1997041883A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	WO1997041874A1 Phosphatidic acid-comprising compositions
11/13/1997	WO1997041851A1 Benzothiophenes, formulations containing same, and methods
11/13/1997	WO1997041834A1 Cationic virosomes as transfer system for genetic material
11/13/1997	WO1997041831A1 Stimulation of immune response with low doses of il-2
11/13/1997	WO1997041824A2 Antiangiogenic peptides derived from plasminogen
11/13/1997	WO1997033996A3 Human bikunin
11/13/1997	WO1997031655A3 Modified cytokines for therapeutic use
11/13/1997	WO1997029195A3 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
11/13/1997	WO1997024116A3 METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY
11/13/1997	DE19619036A1 Neue Vitamin D-Derivate mit carbo- oder heterocyclischen Substituenten an C-25, Verfahren zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with carbo- or heterocyclic substituent at C-25, process for their preparation and the use thereof for producing medicaments
11/13/1997	DE19618727A1 Herstellung alkylierter Nucleosid-3'-Phosphate Preparation of alkylated nucleoside-3'-phosphates
11/13/1997	CA2253971A1 Use of high dose interferon by oralmucosal contact to treat viral infections and neoplastic conditions
11/13/1997	CA2253908A1 Stimulation of host defence mechanisms against tumors
11/13/1997	CA2253904A1 Targeted combination immunotherapy of cancer
11/13/1997	CA2253902A1 Stimulation of host defense mechanisms against viral challenges
11/13/1997	CA2253864A1 Neurotactin and uses therefor
11/13/1997	CA2253858A1 Benzothiophenes, formulations containing same, and methods
11/13/1997	CA2253561A1 Cationic virosomes as transfer system for genetic material
11/13/1997	CA2253322A1 Gene expression in monocytes and macrophages
11/13/1997	CA2250579A1 Monoclonal antibody to cea, conjugates comprising said antibody, and their therapeutic use in an adept system
11/12/1997	EP0806420A1 Benzothiophenes, formulations containing same, and methods
11/12/1997	EP0805871A1 Anti-cd 30 antibodies preventing proteolytic cleavage and release of membrane-bound cd 30 antigen
11/12/1997	EP0805858A2 Inhibition of neovascularization using vegf-specific oligonucleotides
11/12/1997	EP0805807A1 2-(2-amino-3-methoxyphenyl)-4-oxo-4h-(1)benzopyran for treating proliferative disorders
11/12/1997	EP0805690A1 Method for selective methionine starvation of malignant cells in mammals
11/12/1997	EP0805688A1 Use of il-4 for potentiation of chemotherapeutic agents
11/12/1997	EP0805687A1 Recombinant human alpha-fetoprotein and uses thereof
11/12/1997	EP0805682A1 Dermatological use of vitamin d derivatives
11/12/1997	EP0805678A1 Surface-modified nanoparticles and method of making and using same
11/12/1997	EP0600026B1 Cardiac output probe assembly
11/12/1997	CN1164531A Novel derivatives of 3-bromo-and 3,3-dibromo-4-oxo-1-azetidines, processes for preparation thereof and their use
11/11/1997	US5686623 Method for preparing taxane derivatives
11/11/1997	US5686622 Thiazolidine derivatives, their preparation and the medicaments containing the same
11/11/1997	US5686578 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype
11/11/1997	US5686574 Constitutive activator of retinoid acid response (car) receptor fusion protien
11/11/1997	US5686562 Diagnosis and treatment of cancer
11/11/1997	US5686496 Aromatic ether amidine used for treating diseases involve inflammatory and/or allergic processes
11/11/1997	US5686472 Inhibitors of farnesyl-protein transferase
11/11/1997	US5686467 2-phenyl-3-aroylbenzothiophenes
11/11/1997	US5686460 Antiinflammatory agents, analgesics
11/11/1997	US5686459 Anticoagulants
11/11/1997	US5686457 Pyrrolopyrimidine derivatives having pharmacological activity
11/11/1997	US5686439 Chelate complexes and processes for their preparation
11/11/1997	US5686435 Vitamin D amide derivatives
11/11/1997	US5686426 Dicarboxymethylated glycolipid derivatives as cell adhesion inhibitors
11/11/1997	US5686292 Hepatocyte growth factor receptor antagonist antibodies and uses thereof
11/11/1997	US5686278 Methods for enhanced retrovirus-mediated gene transfer
11/11/1997	US5686245 Methods for screening for agents which modulate telomere length
11/11/1997	US5686068 Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof
11/06/1997	WO1997041440A1 Methods for selecting and producing t cell peptide epitopes and vaccines incorporating said selected epitopes
11/06/1997	WO1997041263A1 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
11/06/1997	WO1997041244A1 Vaccines for treatment of lymphoma and leukemia
11/06/1997	WO1997041230A2 Cc-type chemokines
11/06/1997	WO1997041210A1 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with rna
11/06/1997	WO1997041127A1 Halo-substituted protein kinase c inhibitors
11/06/1997	WO1997041115A1 5,6,7,8-TETRAHYDROPYRIDO[2,3-d]PYRIMIDINES
11/06/1997	WO1997041096A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments
11/06/1997	WO1997040857A1 Drug delivery using terminal complement components
11/06/1997	WO1997040855A1 Mammalian regulator of nonsense-mediated rna decay
11/06/1997	WO1997040854A2 Polypeptide conjugates for transporting substances across cell membranes
11/06/1997	WO1997040842A1 Use of protein kinase c inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
11/06/1997	WO1997040837A1 Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2,6-di-alkyl-4-silyl-phenols
11/06/1997	WO1997040835A1 Treatment of carcinomas using squalamine in combination with other anti-cancer agents
11/06/1997	WO1997040830A1 Therapeutic treatment for vegf related diseases

1 ... 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 ... 2211